2025-03-18 Axcelis Technologies, Inc. HaiPress

President and CEO Russell Low will Present Keynote Speech at CS Asia
BEVERLY,Mass.,March 17,2025 -- Axcelis Technologies,Inc. (Nasdaq: ACLS),a leading supplier of enabling ion implantation solutions for the semiconductor industry,announced today that it will be the Diamond Sponsor for the Compound Semiconductor Asia Conference (CS Asia) 2025. The event is being held in conjunction with SEMICON China 2025 on March 25-27,2025,at the Kerry Hotel in Pudong,Shanghai. Axcelis' President and CEO,Russell Low,will present an opening Keynote Speech at the event.
Innovation in Ion Implantation for Power and Compound Semiconductor Devices
Russell Low,PhD
President & CEO,Axcelis Technologies
14:30 – 15:00
Shanghai Ballroom 3,Kerry Hotel
President and CEO Russell Low,said,"We're pleased to be a part of SEMICON China and especially excited about participating in the CS Asia Conference,one of the most important power and compound semiconductor technology forums in the Asia Pacific region. Axcelis is well positioned with a broad portfolio and deep technical expertise in this market,and we look forward to providing our innovative ion implant technology to chipmakers in China."
About Axcelis:
Axcelis (Nasdaq: ACLS),headquartered in Beverly,has been providing innovative,high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design,manufacture and complete life cycle support of ion implantation systems,one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
CONTACTS:
Press/Media Relations Contact:
Maureen Hart
Senior Director,Corporate & Marketing Communications
Telephone: (978) 787-4266
Email: Maureen.Hart@axcelis.com
Axcelis Investor Relations Contact:
David Ryzhik
Senior Vice President,Investor Relations and Corporate Strategy
Telephone: (978) 787-2352
Email: David.Ryzhik@axcelis.com
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Diet Tips Daily